Filter by: patients
Home > Community Treatment Reports and Side Effects > Combivir/Nevirapine Treatment Report
What is Combivir/Nevirapine?

This is a combination of the antiretroviral drug Combivir (a combination of lamivudine and zidovudine (AZT), and Nevirapine (brand name Viramune). This combination may simplify your therapy and reduce the rate of developing resistance to the separate drugs.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 6 0
Swollen glands 1 0
Other 1 0

See all 6 patients currently taking Combivir/Nevirapine

Mouse over the table for more information

Reported Dosages

  daily 2 daily 2 tbs. daily 150 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Combivir/Nevirapine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 67%
Expense 1   Expense: 33%
Personal research 1   Personal research: 33%
Side effects too severe 1   Side effects too severe: 33%
Other 1   Other: 33%

See all 3 patients who’ve stopped taking Combivir/Nevirapine

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Combivir/Nevirapine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Report created on May 24, 2012.